Cardiome Pharma Corp. (CRME) Misses Q3 Loss Views by 2c
Tweet
Share
E-mailGet Alerts CRME Hot Sheet
Join SI Premium – FREE
Cardiome Pharma Corp. (NASDAQ: CRME) reported Q3 loss of ($0.12), $0.02 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $300 thousand versus the consensus estimate of $960 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SelectQuote, Inc. (SLQT) Misses Q4 EPS by 4c ; Offers Guidance
- Pinduoduo (PDD) Tops Q2 EPS by 98c
- Bank of Nova Scotia (BNS) Tops Q2 EPS by 20c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
